Osaka Pharmacology Clinical Research Hospital (OPHAC Hospital)
OPHAC Hospital, Osaka Japan, is the first specialised clinical research hospital to be established in Japan. Focus is currently on phase I studies, however from mid 2006, the hospital's capacity to conduct clinical trials in phases II to IV will also be utilised. OPHAC Hospital is the core affiliated hospital of the highly experienced InCROM Group and can therefore benefit from the group's expertise in the global clinical research field, and with the group's support can provide a comprehensive range of services. OPHAC Hospital endeavours to be a competitive option for the conduct of clinical trials in Japan, whilst achieving superior levels of quality and conducting trials to international standards.
Key Features :
The hospital is designed to meet the needs of both sponsor and subject ensuring trial success and quality.
45 beds secured on 2 floors
Key location for successful recruitment within 7 minutes walk from Shin Osaka station, on the Shinkansen line, therefore has access to a large recruitment area including Osaka, Kobe and Kyoto.
Able to utilise InCROM Group's extensive experience and expertise in clinical research, including its comprehensive SMO/CRO services.
